Loading…
Loading…
Moderna Inc
NASDAQ · Stock Profile · Market Cap $20.47B
Current Price
$52.40
-2.84%GoodMoat Value
$-83.28
258.9% overvaluedA large-cap company with a $20.5B market cap.
Net Cash: 1.3B
241M
FY24
1.9B
FY24
3.2B
FY24
108M
FY25
142M
FY25
1.0B
FY25
1.9B
FY25
—
FY24
13M
FY24
—
FY24
—
FY25
—
FY25
—
FY25
—
FY25
Moderna is a pioneer and leader in the field of mRNA medicine. Through the advancement of its technology platform, Moderna is reimagining how medicines are made to transform how we treat and prevent diseases. Since its founding, Moderna's mRNA platform has enabled the development of vaccines and therapeutics across infectious diseases, cancer, rare diseases and more. With a global team and a unique culture, driven by the company's values and mindsets, Moderna's mission is to deliver the greatest possible impact to people through mRNA medicines.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
Massachusetts, USA
Price sits at 85% of its 52-week range.
Blended fair value estimate based on DCF, Graham Number, and earnings-based models.
Run a full DCF analysis with customizable assumptions
Open DCF Calculator →Graham Number, PEG-based, and Earnings-based models
View Fair Value →This stock does not currently pay a dividend.
Moderna is a pioneer and leader in the field of mRNA medicine. Through the advancement of its technology platform, Moderna is reimagining how medicines are made to transform how we treat and prevent diseases. Since its founding, Moderna's mRNA platform has enabled the development of vaccines and therapeutics across infectious diseases, cancer, rare diseases and more. With a global team and a unique culture, driven by the company's values and mindsets, Moderna's mission is to deliver the greatest possible impact to people through mRNA medicines.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
Massachusetts, USA